Yakira Capital Management, Inc. Provention Bio, Inc. Put Options Transaction History

Yakira Capital Management, Inc.

  • $197 Million
  • Q3 2024

Put Options

1 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2023

May 12, 2023
BUY
$6.7 - $24.21 $160,130 - $578,619
23,900 New
23,900 $575,000

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0
View Full List

About Provention Bio, Inc.

PRVB Quotes by TradingView
  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Yakira Capital Management, Inc. Portfolio

Follow Yakira Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yakira Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Yakira Capital Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email